Bioprospecting of Marine and Terrestrial Organisms for New Therapeutics
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 1167
Special Issue Editors
Interests: genomics; phylogeny; biochemistry; genome bioprospecting
Special Issues, Collections and Topics in MDPI journals
Interests: marine bioprospecting; sea anemone venoms; combinatorial peptide libraries; recombinant peptides
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bioprospecting for biologically active natural products is a well-known tool used in the early stages of drug discovery. The choice of a source for bioprospecting plays an important role in research efforts that is more likely to lead to new drugs. Unique ecosystems unexplored to date such as tundra, desert, salt marshes, and groundwater or mangrove forests are valuable sources of novel products. Advances in high-throughput omics technologies such as proteomics, genomics, and metabolomics have offered wide opportunities for bioprospecting and drug discovery, allowing thousands of molecules to be analyzed simultaneously. Marine ecosystems are an untapped reservoir of biodiversity with enormous potential for bioprospecting of pharmacologically active compounds. As Guest Editors of the Special Issue titled “Genomic Bioprospecting of Marine Species for New Therapeutics” we clearly recognize that marine genome-based bioprospecting is a very new trend. However, we are seeing progress in studies of marine natural products from marine microorganisms due to their biosynthetic gene identification and marine venomous animals due to their transcriptomic studies.
As Guest Editors of the updated Special Issue of Biomedicines named "Bioprospecting of Marine and Terrestrial Organisms for New Therapeutics", we would like to invite scientists who deal with marine or terrestrial bioprospecting to make a highly desirable contribution to nature-derived drug discovery.
Dr. Marina P. Isaeva
Dr. Elena Leychenko
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioprospecting
- marine and terrestrial resources
- drug discovery
- natural products
- peptides
- gene-based screening
- biosynthetic gene cluster
- genome mining
